LIFOLZA
Live / Registered — Registered (as of 10 Feb 2026)
What this means for you
Registered since 10 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79429331
- Registration number
- 8131906
- Mark type
- Stylized text
- Filed
- 05 Jun 2025
- Published for opposition
- 23 Dec 2025
- Registered
- 10 Feb 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for the prevention and treatment of lysosomal storage disorders, in particular Gaucher Disease, as well as of diseases and disorders affecting the central and peripheral nervous systems, including movement disorders, Parkinson's disease, and related parkinsonian conditions.
Owner
Prosecution history
- 12 Mar 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 10 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 18 Dec 2025 — NOTIFICATION PROCESSED BY IB
- 17 Dec 2025 — NOTICE OF PUBLICATION
- 03 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 02 Dec 2025 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 18 Nov 2025 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 29 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Oct 2025 — ASSIGNED TO EXAMINER
- 07 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 07 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Aug 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB